Cargando…
Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer
This trial was designed to assess efficacy and safety of erlotinib with sorafenib in the treatment of patients with advanced pancreatic adenocarcinoma. An exploratory correlative study analyzing pretreatment serum samples using a multivariate protein mass spectrometry-based test (VeriStrat®), previo...
Autores principales: | Cardin, Dana B, Goff, Laura, Li, Chung-I, Shyr, Yu, Winkler, Charles, DeVore, Russell, Schlabach, Larry, Holloway, Melanie, McClanahan, Pam, Meyer, Krista, Grigorieva, Julia, Berlin, Jordan, Chan, Emily |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101748/ https://www.ncbi.nlm.nih.gov/pubmed/24574334 http://dx.doi.org/10.1002/cam4.208 |
Ejemplares similares
-
VeriStrat(®) has prognostic value in advanced stage NSCLC patients treated
with erlotinib and sorafenib
por: Kuiper, J L, et al.
Publicado: (2012) -
A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers
por: Goff, Laura W., et al.
Publicado: (2016) -
Practical problems in mathematics for heating and cooling technicians
por: DeVore, Russell
Publicado: (1998) -
Instructor's guide to accompany practical problems in mathematics for heating & cooling technicians
por: DeVore, Russell
Publicado: (1998) -
Recent advances in the treatment of pancreatic cancer
por: Roth, Marc T, et al.
Publicado: (2020)